how many people in us are on glp 1 Patrick Oben | 9 Americans now take a GLP-1 medication. That's 11% of U.S. adults — up from just 3% in 2024. Nearly quadrupled in two years. But The GLP-1 Access Gap: Mapping

Benefits: Skin Brightening & Even Tone: Glutathione reduces melanin production for a lighter, radiant complexion

Patients with existing medical conditions might be at an increased risk for complications, which necessitates close monitoring of Glutathione levels in order to tailor the dosage according to individual tolerance and medical history

Increased Risk of Low Blood Sugar (Even in Non-Diabetics) GLP-1 meds lower glucose

Ipamorelin is studied for growth hormone insufficiency, body composition, aging, and metabolic health in preclinical models

Vincenzo V, Dimitrios PB

doi: 10.1111/j.1365-2982.2012.01893 24 DunlopB